Pitfalls and problems in immunoanalysis

Abstract The quality and reliability of laboratory test results, and more specifically immunoassay results, depend not only on analytical accuracy and precision, but also on technical skill and knowledge of potential pitfalls and problems. It must be recalled that despite their widespread use, immunoassays can, in some circumstances, be defective. Pitfalls must be avoided from the pre-analytical phase onwards. At the analytical level, problems related to the Hoock and matrix effects as well as standardisation and interference problems that may affect all immunoassays will be discussed.

[1]  L. Bordenave,et al.  False-positive results corrected by the use of heterophilic antibody-blocking reagent in thyroglobulin immunoassays. , 2008, Clinica chimica acta; international journal of clinical chemistry.

[2]  D. Chan,et al.  Is the WHO 90:10 prostate-specific antigen (PSA) first international reference standard really 90% α1-antichymotrypsin-bound PSA and 10% free PSA? , 2011, Clinical chemistry.

[3]  C. Selby,et al.  Interference in Immunoassay , 1999, Annals of clinical biochemistry.

[4]  R. Rousson,et al.  Unnecessary coronary angiography due to false positive troponin I results in a 51-year-old man. , 2007, Clinica chimica acta; international journal of clinical chemistry.

[5]  J. Long,et al.  PSA measurement following prostatectomy: an unexpected error. , 2007, Anticancer research.

[6]  J. Cadeddu,et al.  Spurious prostate‐specific antigen (PSA) recurrence after radical prostatectomy: Interference by human antimouse heterophile antibodies , 2007, International journal of urology : official journal of the Japanese Urological Association.

[7]  Michael Cookson,et al.  Spurious elevation of serum PSA after curative treatment for prostate cancer: clinical consequences and the role of heterophilic antibodies , 2011, Prostate Cancer and Prostatic Diseases.

[8]  L. Boscato,et al.  Heterophilic antibodies: a problem for all immunoassays. , 1988, Clinical chemistry.

[9]  J. Franklyn,et al.  Can we interpret serum thyroglobulin results? , 2012, Annals of clinical biochemistry.

[10]  O. Cussenot,et al.  Inappropriate treatment of prostate cancer caused by heterophilic antibody interference , 2009, Nature Clinical Practice Urology.

[11]  G. Charriere,et al.  Hook effect in immunometric assays for prostate-specific antigen. , 1995, Clinical chemistry.

[12]  R. Hauke,et al.  New onset of heterophilic antibody interference in prostate-specific antigen measurement occurring during the period of post-prostatectomy prostate-specific antigen monitoring , 2009, Annals of clinical biochemistry.

[13]  G. Brabant,et al.  TSH Isoforms: About a Case of Hypothyroidism in a Down's Syndrome Young Adult , 2010, Journal of thyroid research.